study

  1. Wyva

    Preprint Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through (...), 2023, Fekete et al

    Full title: Infection-induced vascular inflammation in COVID-19 links focal microglial dysfunction with neuropathologies through IL-1/IL-6-related systemic inflammatory states Abstract COVID-19 is associated with diverse neurological abnormalities, which predict poor outcome in patients...
  2. Wyva

    Analysis of microvascular and neurodegenerative complications of mild COVID-19, 2022, Kolkedi et al

    Abstract Purpose To examine retinal and corneal neurodegenerative and retinal microvascular changes in patients after mild or asymptomatic COVID-19 disease compared to age-matched controls. Methods Thirty-five (35) patients after PCR-proven SARS-CoV-2 infection and 28 age-matched controls were...
  3. Wyva

    Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study, 2023, Pearson et al

    Abstract Post-COVID-19 condition, also known as long COVID-19 syndrome and post-acute sequelae of SARS-CoV-2, encompasses an array of symptoms that persist well beyond the initial phase of the viral infection. These symptoms can range in intensity, from mild and manageable to severe and...
  4. Wyva

    Gray Matter Changes Following Mild COVID-19: An MR Morphometric Study in Healthy Young People, 2023, Janszky et al

    Abstract Background Although COVID-19 is primarily an acute respiratory infection, 5%–40% of patients develop late and prolonged symptoms with frequent neurological complaints, known as long COVID syndrome. The presentation of the disease suggests that COVID infection may cause functional...
  5. Wyva

    Cognitive functioning in POTS among different body positions: a prospective pilot study (POTSKog study), 2023, Maier et al

    Full title: Cognitive functioning in postural orthostatic tachycardia syndrome among different body positions: a prospective pilot study (POTSKog study) Abstract Purpose Approximately 96% of patients with postural orthostatic tachycardia syndrome (PoTS) report cognitive complaints. We...
  6. Wyva

    Alcohol intolerance and myalgic encephalomyelitis/chronic fatigue syndrome, 2023, Maciuch, Jason

    Abstract BACKGROUND The literature is mixed about the occurrence of alcohol intolerance among patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Surveys that asked respondents with ME/CFS whether they experienced alcohol intolerance within a recent time frame might...
  7. Wyva

    Short and mid-term characteristics of COVID-19 disease course in athletes: A high-volume, single-center study, 2022, Juhász et al

    Abstract Introduction At the pandemic's beginning, significant concern has risen about the prevalence of myocardial involvement after SARS-CoV-2 infection. We assessed the cardiovascular burden of SARS-CoV-2 in a large cohort of athletes and identified factors that might affect the disease...
  8. Wyva

    Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following (...), 2023, Achleitner et al

    Full title: Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis Abstract In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most...
  9. Wyva

    Impact of the COVID-19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology and(...), 2023, Fanciulli et al

    Full title: Impact of the COVID-19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology (EAN) and the European Federation of Autonomic Societies (EFAS) Abstract Objective To investigate the impact of the coronavirus-disease-2019 (COVID-19) pandemic...
  10. Wyva

    Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants, 2022, Magnusson et al

    Abstract The SARS-CoV-2 Omicron (B.1.1.529) variant has been associated with less severe acute disease, however, concerns remain as to whether long-term complaints persist to a similar extent as for earlier variants. Studying 1 323 145 persons aged 18-70 years living in Norway with and...
  11. Wyva

    Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA), 2023, Griffith et al

    Abstract Background Symptom persistence in non-hospitalized COVID-19 patients, also known as Long COVID or Post-acute Sequelae of COVID-19, is not well characterized or understood, and few studies have included non-COVID-19 control groups. Methods We used data from a cross-sectional COVID-19...
  12. Wyva

    ME/CFS and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study, 2023, van Eeden et al

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study Summary Background Persistent fatigue is a common complaint in ANCA-vasculitis (AAV) patients and has a profound impact on patient's...
  13. Art Vandelay

    Exercise & Sports Science Australia funds graded exercise study for Long COVID, 2023

    Moved posts Graded Exercise for Long Covid. How groundbreaking:
  14. RedFox

    Protocol RECOVER Treatment Study: Paxlovid for long Covid

    The RECOVER Initiative is doing a trial on Paxlovid for long Covid. Here's the listing on ClinicalTrials.gov: SARS CoV-2 Viral Persistence Study (PASC) - Study of Long COVID-19 (PASC) Highlights: Double-blind multi-center trial in the US 1700 participants They'll take the drug for 15 days...
  15. Wyva

    Differences in outcomes after total hip arthroplasty for osteoarthritis between pts with and without CS syndromes other than FM, 2022, Ohashi et al

    Full title: Differences in outcomes after total hip arthroplasty for osteoarthritis between patients with and without central sensitivity syndromes other than fibromyalgia Abstract We investigated the differences in outcomes after total hip arthroplasty (THA) for hip osteoarthritis (HOA)...
  16. Wyva

    The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and (...), 2022, Nehme et al

    Full title: The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization Abstract Post-COVID condition is prevalent in 10–35% of cases in outpatient settings, however a stratification of the duration and...
  17. Wyva

    The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients, 2022, Goulabchand et al

    Abstract Primary Sjögren’s syndrome (pSS) is an autoimmune disease with frequent neurological involvement. Memory complaints are common, but their precise patterns remain unclear. We wanted to characterize patterns of neurocognitive profiles in pSS patients with cognitive complaints. Only pSS...
  18. Wyva

    Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19, 2022, Tejerina et al

    Abstract Background There is a paucity of knowledge on the long-term outcome in patients diagnosed with COVID-19. We describe a cohort of patients with a constellation of symptoms occurring four weeks after diagnosis causing different degrees of reduced functional capacity. Although different...
  19. Wyva

    Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome following Infectious Mononucleosis, 2022, Jason et al

    Abstract Background: About 10% of individuals who contract infectious mononucleosis (IM) have symptoms 6 months later that meet criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Our study for the first time examined whether it is possible to predict who will develop...
  20. Wyva

    How mycobacterium tuberculosis infection could lead to the increasing risks of CFS and the potential immunological effects (...), 2022, Yang et al

    Full title: How mycobacterium tuberculosis infection could lead to the increasing risks of chronic fatigue syndrome and the potential immunological effects: a population-based retrospective cohort study Abstract Background Chronic fatigue syndrome (CFS) has been shown to be associated with...
Back
Top Bottom